Physician

Blake Maxwell Hampton, MD

According to 2025 Medicare claims, Blake Hampton, MD (NPI: 1831682962) practices ophthalmology in the Burlington, NC market, with the plurality of this provider's patient population coming from Alamance, NC. This provider's primary affiliated billing organization is ALAMANCE EYE CARE, PA (NPI: 1184641524; TIN: 56-1973223) and primary practice location at 27215-9714. Hampton is affiliated with the Triad HealthCare Network, LLC. (ACO ID: D0209), participating under the REACH model.

Hampton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 487 traditional Medicare patients, billed 1,097 HCPCS/CPT codes, and received $86,102 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 1,065 prescription claims across 322 beneficiaries totaling $149,122 in drug costs, led by Xiidra (Lifitegrast). Open Payments data shows 24 records totaling $996. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $421 to $149,122. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$43K$86K2023 Medicare payment: $75,582 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $86,102 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023422951$75,582
20244871,097$86,102

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$75K$149K2018 Drug cost: $421 (USD; Tot_Drug_Cst)2019 Drug cost: $5,472 (USD; Tot_Drug_Cst)2020 Drug cost: $16,482 (USD; Tot_Drug_Cst)2021 Drug cost: $11,988 (USD; Tot_Drug_Cst)2022 Drug cost: $10,606 (USD; Tot_Drug_Cst)2023 Drug cost: $39,261 (USD; Tot_Drug_Cst)2024 Drug cost: $149,122 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R15$421
20192373$5,472
202034231$16,482
202140235$11,988
202236131$10,606
2023205497$39,261
20243221,065$149,122

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system142142$93
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more6069$88
92014Established patient complete exam of visual system165173$85
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more120170$61
92134Imaging of retina6790$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XiidraLifitegrast251,590$35,318
RestasisCyclosporine151,230$24,551
MieboPerfluorohexyloctane/Pf14397$10,364
CequaCyclosporine12420$8,237
LumiganBimatoprost21721$6,515

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.24$996BIOTISSUE HOLDINGS INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Blake Maxwell Hampton, MD?

Tedicare shows public-source Medicare data for Blake Maxwell Hampton, MD (NPI 1831682962), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Blake Maxwell Hampton, MD have ACO affiliation data?

Blake Maxwell Hampton, MD is shown with ACO affiliation data for Triad HealthCare Network, LLC. (REACH, ACO ID D0209).

What billing organization is linked to Blake Maxwell Hampton, MD?

Blake Maxwell Hampton, MD is linked to ALAMANCE EYE CARE, PA (billing NPI 1184641524) in the available physician profile data.

Does Blake Maxwell Hampton, MD have Open Payments data?

Blake Maxwell Hampton, MD has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.